UnitedHealth Stock Dips After Analyst Price Target Cut
UnitedHealth Group (UNH) shares fell 1.5% Tuesday, underperforming the S&P 500's 0.6% decline, after SocGen analyst Lance Wilkes slashed his price target from $594 to $377. While maintaining an outperform rating, Wilkes cited weak projected performance through 2026, reducing his earnings per share estimate by 13% and cutting the target P/E ratio to 12.5 from 18.
The downgrade follows Monday's gains fueled by a separate analyst upgrade, demonstrating the stock's sensitivity to Wall Street sentiment. Sluggish growth in UnitedHealth's OptumHealth unit contributed to the pessimistic outlook. Notably, the healthcare giant recently attracted attention when Warren Buffett's Berkshire Hathaway disclosed a $1.6 billion stake.